|
|
||||||||
Cerebrovascular Research Center, Departments of Neurology and Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
Correspondence: For reprints contact: Joel H. Greenberg, PhD, Cerebrovascular Research Center, 429 Johnson Pavilion, University of Pennsylvania, Philadelphia, PA 19104.
ABSTRACT
We studied the radioisotope iodine-123-iodoamphetamine ([123I]IMP) and its performance in single-photon emission computed tomographic (SPECT) studies of cerebral blood flow (CBF). In seven normal volunteers, IMP/SPECT CBF measurements were calculated using a two-compartment model and were compared with the results of CBF measurements utilizing (O15)-H2O and positron emission tomography (PET). Calculated mean PET CBF was 57.6 ml/100g/min while the SPECT CBF value was 47.3 ml/100 g/min. The response of IMP/SPECT CBF to alterations in arterial PaCO2 was studied in hypo-, eu- and hypercarbic subjects. SPECT CBF values showed a reactivity of 1.03 ml/100 g/min per mmHg PaC02 change.These results show that the IMP/SPECT CBF technique may be used for quantitative imaging of CBF in man. They provide further support for IMP as a CBF tracer.
This article has been cited by other articles:
![]() |
A. S. Arbab, S. Aoki, K. Toyama, N. Miyazawa, H. Kumagai, T. Umeda, T. Arai, T. Araki, H. Kabasawa, and Y. Takahashi Quantitative Measurement of Regional Cerebral Blood Flow with Flow-Sensitive Alternating Inversion Recovery Imaging: Comparison with [Iodine 123]-Iodoamphetamin Single Photon Emission CT AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 381 - 388. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |